785806-96-4Fluticasone Furoate EP Impurity G
● In Stock
| Catalogue No.: | VE0016399 |
|---|---|
| CAS No.: | 785806-96-4 |
| Mol. Formula: | C27H29ClF2O6S |
| Mol. Weight: | 555.03 g/mol |
Additional information on CAS 785806-96-4
Parent drug
FluticasoneIUPAC Name
9-Chloro-6α-fluoro-17β-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl furan-2-carboxylateSynonyms
N/ASmiles
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)Cl)C)FPharmacopeial Synonyms
N/AInChI
InChI=1S/C27H29ClF2O6S/c1-14-9-16-17-11-19(30)18-10-15(31)6-7-24(18,2)26(17,28)21(32)12-25(16,3)27(14,23(34)37-13-29)36-22(33)20-5-4-8-35-20/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3/t14-,16+,17+,19+,21+,24+,25+,26+,27+/m1/s1Description
Fluticasone Furoate EP Impurity G, CAS 785806-96-4, is a defined process-related impurity associated with the fluorinated corticosteroid fluticasone furoate. With molecular formula C27H29ClF2O6S and molecular weight 555.03 g/mol, it represents a structurally related chlorofluorinated sulfoxide-containing derivative requiring precise chromatographic differentiation from the API and closely allied degradants. Its origin is consistent with synthetic side-product formation or oxidative transformation during manufacturing and storage. Determination typically relies on stability-indicating RP-HPLC coupled to LC-MS/MS, with confirmatory HRMS or NMR characterization when structural assignment is required under pharmacopeial and impurity-control frameworks.Request a Quote
"*" indicates required fields

